A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer
- DOI
- 10.1093/oncolo/oyag180
- Published
- 2026-05-08
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyag180,
title = {A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer},
author = {Julie N Graff and Claire E P Smith and Alexandra O Sokolova and David Z Qian and Tomasz M Beer and Emile Latour and Shawna Bailey and Dustin Kreitner and Petros Grivas and Michael T Schweizer and Celestia S Higano and Joshi J Alumkal and Jacqueline Vuky and Evan Y Yu and Heather H Cheng},
year = {2026},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyag180},
url = {https://doi.org/10.1093/oncolo/oyag180}
}RIS
TY - JOUR TI - A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer AU - Julie N Graff AU - Claire E P Smith AU - Alexandra O Sokolova AU - David Z Qian AU - Tomasz M Beer AU - Emile Latour AU - Shawna Bailey AU - Dustin Kreitner AU - Petros Grivas AU - Michael T Schweizer AU - Celestia S Higano AU - Joshi J Alumkal AU - Jacqueline Vuky AU - Evan Y Yu AU - Heather H Cheng PY - 2026 JO - The Oncologist DO - 10.1093/oncolo/oyag180 UR - https://doi.org/10.1093/oncolo/oyag180 ER -
APA
Graff, J. N., Smith, C. E. P., Sokolova, A. O., Qian, D. Z., Beer, T. M., Latour, E., Bailey, S., Kreitner, D., Grivas, P., Schweizer, M. T., Higano, C. S., Alumkal, J. J., Vuky, J., Yu, E. Y., & Cheng, H. H. (2026). A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. The Oncologist. https://doi.org/10.1093/oncolo/oyag180
Source records
- crossref · retrieved 2026-09-26T22:04:03.933Z